Mesoblast Limited (NASDAQ:MESO) – Analysts at Cantor Fitzgerald boosted their FY2018 earnings per share estimates for shares of Mesoblast in a research report issued to clients and investors on Monday, Zacks Investment Research reports. Cantor Fitzgerald analyst E. Piros now forecasts that the company will post earnings per share of ($0.80) for the year, up from their previous estimate of ($1.16). Cantor Fitzgerald has a “Buy” rating and a $20.00 price target on the stock.
Several other analysts also recently issued reports on the company. Maxim Group set a $14.00 price target on Mesoblast and gave the stock a “buy” rating in a research note on Wednesday, August 16th. ValuEngine downgraded Mesoblast from a “hold” rating to a “sell” rating in a research note on Friday, September 15th. Oppenheimer set a $16.00 price target on Mesoblast and gave the stock a “buy” rating in a research note on Tuesday, November 14th. Zacks Investment Research downgraded Mesoblast from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Finally, CIBC initiated coverage on Mesoblast in a research note on Thursday, August 31st. They set an “outperform” rating and a $16.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $13.14.
Mesoblast (NASDAQ MESO) opened at $5.23 on Wednesday. Mesoblast has a 52-week low of $4.46 and a 52-week high of $12.50.
TRADEMARK VIOLATION NOTICE: This article was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.thelincolnianonline.com/2017/12/08/mesoblast-limited-meso-to-post-fy2018-earnings-of-0-80-per-share-cantor-fitzgerald-forecasts-updated-updated-updated.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with MarketBeat.com's FREE daily email newsletter.